AI for Batch Review: 7 Factors to Consider
AI for Batch Review: 7 Factors to Consider
×
Calendar Icon 12 August 2026
Clock Icon 3 min
/ AI for Batch Review

7 Factors to Consider Before Using AI for Batch Review

AI-assisted batch review can help pharmaceutical manufacturers improve review efficiency, but its effectiveness depends on the underlying data, traceability, compliance controls, and system architecture. This video covers seven factors QA and manufacturing teams should consider before implementing AI for batch review.

About this Video

With Mareana, you can connect batch genealogy, lot traceability, electronic batch records, quality data, and AI-assisted review across source systems to support compliant, traceable, and more confident manufacturing decisions.

.

What You'll Learn

Learn the critical considerations for implementing AI-assisted batch review in pharmaceutical manufacturing, from connected batch genealogy and Part 11 compliance to audit trails, traceability, recall management, and manufacturing intelligence.

Understand why connected batch genealogy and data relationships are foundational to AI-assisted batch review

Identify the compliance, audit trail, and traceability requirements that apply to AI-enabled GXP workflows

See how connected EBRs, manufacturing data, and genealogy support faster recall analysis and more confident batch decisions

Full Transcript

Access the complete word-for-word transcript for easy reference and accessibility.

Show Transcript
Toggle Transcript
0:00 - 0:15

7 Factors You Should Know Before Using AI for Batch Reviews. 1. Batch genealogy is the foundation, not a feature. Most legacy systems store batch data in flat tables or disconnected silos. A knowledge graph architecture, by contrast, stores genealogy as connected nodes and relationships, preserving complex, many-to-many mappings.

0:15 - 0:30

Without it, AI-assisted review is making decisions on incomplete information. 2. 21 CFR Part 11 Compliance covers the AI, not just the records. 21 CFR Part 11 Compliance applies to the electronic system that creates, modifies, stores, or transmits regulated electronic records, including AI-enabled systems used in GXP workflows.

 

0:30 - 0:45

21 CFR Part 11 Compliance applies to the electronic system that creates, modifies, stores, or transmits regulated electronic records, including AI-enabled systems used in GXP workflows. When an AI model generates a recommendation that is used as part of a GXP decision…

0:45 - 1:00

…that output may be a regulated electronic record, and the surrounding system controls must support Part 11 expectations. 3. Audit trails for AI systems require more than timestamps. A compliant audit trail for a traditional electronic batch record captures who did what, when, and why.

1:00 - 1:15

For AI-assisted batch review, the audit trail must also capture what the AI did, which model version it used what inputs it consumed, and how it arrived at its output.

1:15 - 1:30

The Alcoa++ framework applies to AI-generated records just as it does to human-entered data. 4. Traceability must work backward and forward. Both directions matter for batch review.

1:30 - 1:45

An AI system reviewing a batch for release needs forward traceability to confirm that all incoming materials met specifications, and backward traceability to verify that no upstream deviation has been left unresolved. 5. Electronic batch records are only as good as their connections.

1:45 - 2:00

An EBR captures the production record for a single batch. AI-assisted review requires connecting that EBR to analytical results from LIMS, environmental monitoring data, equipment qualification records deviation and kappa histories, and incoming material certificates of analysis. When those connections are absent, the batch record is an island of data surrounded by manual lookup.

2:00 - 2:15

6. Recall management depends on speed you can’t get manually. When a recall is triggered, QA teams need to identify every affected batch, every downstream customer, and every upstream material lot. AI batch review software that stores genealogy as a connected graph can run these impact analyses in minutes.

2:15 - 2:30

Systems that manual cross-referencing across ERP, MES, LIMS, and paper records will not meet that standard.

2:30 - 2:45

7. Manufacturing intelligence ties it all together. Manufacturing intelligence is the layer that transforms batch genealogy, lot traceability, electronic batch records, and AI-assisted review from isolated capabilities into a unified operational system.

2:45- 3:00

It is the discipline of connecting, contextualising, and analysing manufacturing data across all source systems to enable faster, more confident decisions.

/ ANY QUESTIONS? WE'D LOVE TO HELP

Frequently Asked Questions

Mareana has helped numerous firms in the Pharmaceutical, Chemical, Medical Device, and Industrial Manufacturing industries.

AI-assisted batch review uses artificial intelligence to analyze electronic batch records and connected manufacturing data to help identify issues, verify traceability, and support faster, more informed batch-release decisions.

Batch genealogy provides the connected relationships between batches, materials, equipment, processes, and other manufacturing records. Without complete genealogy, AI may make recommendations using incomplete information.

Yes. When an AI-enabled system creates, modifies, stores, or transmits regulated electronic records in a GxP workflow, the system and its controls may need to support applicable 21 CFR Part 11 expectations.

An AI audit trail should capture more than timestamps and user actions. It should provide appropriate traceability of what the AI did, the model version used, the inputs considered, and the resulting output or recommendation.

Bidirectional traceability helps QA teams verify both upstream and downstream relationships. It can confirm that incoming materials met specifications while also helping identify unresolved upstream deviations or affected downstream batches.

AI-assisted batch review systems with connected batch genealogy can rapidly identify affected batches, downstream customers, and upstream material lots. This can reduce the need for slow manual cross-referencing across ERP, MES, LIMS, and paper records.

Contact Us

Would you like to learn more about our pharmaceutical manufacturing solutions? Fill out the form below and one of our experts will reach out to you promptly.

By submitting your details, you agree to our Privacy Policy and to receive email communications from Mareana. You may unsubscribe at any time.

Lessons from the First FDA Warning Letter on AI Misuse
/ BEFORE YOU GO

Lessons from the First FDA Warning Letter on AI Misuse

By signing up, you agree to the Privacy Policy.